Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 63

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 19
Chunk 63
---
6           656,441         1,717,995  
  Intangible assets                                  7            59,147            46,649  
  Total Assets                                                 2,298,544         2,538,205  
  LIABILITIES                                                                               
  Current Liabilities                                                                       
  Accounts payable and accrued liabilities           8           330,817           489,218  
  Loans payable                                      9                 -            40,000  
  Liabilities                                                    330,817           529,218  
  SHAREHOLDERS’ EQUITY                                                                      
  Share capital                                     10        27,304,793        27,186,114  
  Reserves                                          10         7,067,518         6,558,433  
  Accumulated other comprehensive loss                              ( 47                 -  
  Deficit                                                   ( 32,404,537      ( 31,735,560  
  Shareholders                                                 1,967,727         2,008,987  
  Total Liabilities and Shareholders’ Equity                   2,298,544         2,538,205  

Nature
of operations and going concern (Note 1)

Approved
and authorized for issuance on behalf of the Board of Directors on April 30, 2025.

  “ Hector               “ David         
  Hector                 David           

The
accompanying notes are an integral part of these consolidated financial statements

  55  

Avricore
Health Inc.

Consolidated Statements of Operations and Comprehensive Loss

For the years ended December 31, 2024, 2023 and 2022

(Expressed
in Canadian Dollars)

                                                                Note                                                     
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Revenue                                                    14 & 18        4,785,711        3,485,147        1,768,374  
  Cost of sales                                                           ( 2,905,424      ( 2,281,751      ( 1,311,581  
  Gross profit                                                              1,880,287        1,203,396          456,793  
  Expenses                                                                                                               
  Advertising and promotion                                                         -            1,035            2,961  
  Amortization                                                     6            3,137            2,347              631  
  Consulting                                                      12          276,000          236,117